Cargando…

The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis

Background: The incidence and mortality rates of hepatocellular carcinoma (HCC) are increasing worldwide. Therefore, there is an urgent need to elucidate the molecular drivers of HCC for potential early diagnosis and individualized treatment. Whether c-Myc expression plays a role in the clinicopatho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Zhao, Xunlei, Zhang, Haizhen, Chen, Wenjing, Zhao, Haiyan, Yu, Xiaoyun, Lu, Jianyun, Zhou, Xudong, Chen, Aiguo, Shen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581052/ https://www.ncbi.nlm.nih.gov/pubmed/36303795 http://dx.doi.org/10.3389/fbinf.2021.706835

Ejemplares similares

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
por: He, Fei-Yan, et al.
Publicado: (2022)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis
por: Zhang, Xunlei, et al.
Publicado: (2020)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
por: Wang, Zhonghao, et al.
Publicado: (2017)

Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2021)

Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
por: Wang, Qingqing, et al.
Publicado: (2021)

Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma
por: Shi, Weidong, et al.
Publicado: (2020)

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
por: Chen, Yanming, et al.
Publicado: (2021)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma
por: Yang, Xiaolin, et al.
Publicado: (2020)

Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
por: Xie, Shucai, et al.
Publicado: (2019)

MYC overexpression with its prognostic and clinicopathological significance in breast cancer
por: Qu, Jingkun, et al.
Publicado: (2017)

DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer
por: Chang, Xiaojing, et al.
Publicado: (2021)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma
por: Li, Ming, et al.
Publicado: (2020)

Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
por: Ma, Xi, et al.
Publicado: (2020)

Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
por: Wei, Ran, et al.
Publicado: (2023)

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer
por: Zhang, Mingdi, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis
por: Chen, Xin, et al.
Publicado: (2020)

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
por: Fan, Demin, et al.
Publicado: (2020)

EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023)

Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion
por: Ma, Rulan, et al.
Publicado: (2023)

Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma
por: Wan, Sizhe, et al.
Publicado: (2020)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Sun, Ping, et al.
Publicado: (2019)

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data
por: He, Yunan, et al.
Publicado: (2020)

Deep learning for MYC binding site recognition
por: Fioresi, R., et al.
Publicado: (2022)

Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data
por: Ye, Guanzhi, et al.
Publicado: (2019)

Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2020)

Clinicopathological value of long non-coding RNA profiles in gastrointestinal stromal tumor
por: Zhao, Yan, et al.
Publicado: (2021)

Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma
por: Ma, Linkun, et al.
Publicado: (2019)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma
por: Liu, Danqi, et al.
Publicado: (2020)

Functional drug–target–disease network analysis of gene–phenotype connectivity for curcumin in hepatocellular carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_enl5auibuhldo2gr9qja93e2gf